Chris Markoch - Page 9

Latest

It's Time to Go Shopping For Burlington Stock

Brick-and-mortar retail is beating long odds in the last 12 months and BURL stock is rewarding investors who went along for the ride. With a strong earnings report expected on May 27, there's still time to invest in Burlington Stores.  

Take-Two Stock Is Putting Bullish Investors at a Crossroads

After gapping up twice following a bullish earnings report, TTWO stock is putting bulls at a crossroads. Forward guidance suggests the stock may be priced right. But bullish sentiment may be enough to push the stock back over $200.

What More Does Golden Nugget Have to Prove?

Golden Nugget Online Gaming is trying to find a base of support despite the company delivering an earnings report that shows its expansion efforts are proceeding nicely. This article provides three reasons why investors may be holding back on GNOG stock.

Will Positive Earnings Change the Trajectory of Booz Allen Hamilton Stock?

Shares of Booz Allen Hamilton (NYSE:BAH) stock are struggling to find direction in advance of the company’s earnings report on May 21, 2021. Investors in the data analytics company have had a volatile ride so far in 2021.  

Legal Issues Behind It, IBIO Stock May Be a Long Play For Risk-Tolerant Investors

iBio remains a dark horse in the ongoing development of Covid-19 vaccines. But an intriguing new candidate and a resolution of intellectual property issues makes a long, albeit small position in IBIO stock justified for risk-tolerant investors.

3 Retail Stocks to Watch This Week

Retail stocks were a surprising winner in 2020 as consumers quickly shifted to e-commerce during the Covid-19 pandemic. With many consumers now returning to in-person shopping, here are three retail stocks with upside heading into earnings.  

Vroom Stock Will Need More Than One Good Earnings Report

If you owned shares of Vroom (NASDAQ:VRM) stock the day after the company reported earnings, you are breathing a sigh of relief. The company’s shares are soaring over 10% in after-hours and pre-market trading.

Choice Hotels Is Leaving Investors With Few Choices But to Hold On

There's a lot to like about CHH stock, but with demand still being uneven, the company is hesitating to give forward guidance which doesn't give investors much reason to buy the stock at its current valuation. Still, the possibility of a reinstated dividend in the summer may be reason enough to hold the stock.

If You’re Only Looking at Disney+ You’re Missing the Story of DIS stock

The Walt Disney Company (NYSE:DIS) reports earnings after the market closes on May 13. Many eyes will be watching the new subscriber numbers for Disney+, the company’s streaming service.

Wendy’s Needs More Clarity Than an Earnings Report Can Provide

Wendy’s (NASDAQ:WEN) will report earnings on May 12 before the market opens. The whisper number suggests the company will narrowly beat on the bottom line with earnings per share (EPS) coming in at 15 cents per share which is a penny higher than the consensus estimate of 14 cents.

When it Comes to Dividend Stocks, Duke Energy Still Looks Like a King

Duke Energy (NYSE:DUK) continues to charge higher on higher volume after a split result on its earnings report. The utility giant delivered earnings that beat analysts’ expectations.

Inovio Bulls Could Use a Shot of Good News

Inovio (NASDAQ:INO) stock is staging a mini-rally over the last five days in advance of what is expected to be a mixed earnings report. Analysts are forecasting negative earnings per share (EPS) of 20 cents.

Look For a Spot to Buy This Dip in Align Technology Stock

After reporting blowout first-quarter earnings after the market closed on April 28, Align Technology (NASDAQ:ALGN) stock took a sharp break to the upside on higher-than-average volume in early trading 

AbbVie Remains One of the Best Buys in Its Sector

AbbVie (NYSE:ABBV) will be among the stocks closing out a busy earnings week. Earnings season tends to draw a lot of interest from investors, but it’s not always the best indicator of a stock’s overall trajectory.

Is the Rally Ready to Begin for BioMarin Pharmaceutical?

BMRN stock is consolidating on light volume prior to earnings.  The company is projected to report earnings and revenue that are lower on a year-over-year basis. With a potential upside of over 46%, that could make BioMarin an attractive buying option.